FIM
NEO icon

Freedom Investment Management’s NeoGenomics NEO Stock Holding History

Freedom Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,596
Closed -$396K – 890
2021
Q4 		$396K Buy
11,596
+421
+4% +$16.5K 0.03% 595
2021
Q3 		$539K Sell
11,175
-1,282
-10% -$59.3K 0.04% 480
2021
Q2 		$563K Sell
12,457
-1,018
-8% -$45.1K 0.04% 502
2021
Q1 		$650K Buy
+13,475
New +$702K 0.05% 437

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Freedom Investment Management's NEO Position: Q1 2022 in Review

Freedom Investment Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 11,596 shares — an estimated $396K sold.

Freedom Investment Management first reported a position in NEO in Q1 2021 and held it in 4 quarters. The position peaked at $650K in Q1 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Freedom Investment Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 11,596 NeoGenomics shares in Q1 2022, an estimated $396K.
  • Freedom Investment Management first reported a position in NeoGenomics in Q1 2021 and held it in 4 quarters.
  • Freedom Investment Management's NeoGenomics position peaked at $650K in Q1 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.